Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BUX.CN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
-0.01
vs NA
Q4.22
N/A
-0.00
vs NA
Q1.23
N/A
-0.01
vs NA
Q2.23
N/A
-0.01
vs NA
Q3.23
N/A
-0.00
vs -0.01
Q4.23
N/A
-0.00
vs -0.00
Q1.24
N/A
NA
vs -0.01
Q2.24
N/A
NA
vs -0.01
Q3.24
N/A
NA
vs -0.00
Q4.24
N/A
NA
vs -0.00
Sales Growth
YoY
Current
Estimates
Q3.22
NA
41K vs NA
Q4.22
+86%
36.9K vs 19.8K
Q1.23
+65%
39.7K vs 24.1K
Q2.23
+11%
39.7K vs 35.9K
Q3.23
+3%
42.1K vs 41K
Q4.23
+13%
41.5K vs 36.9K
Q1.24
+0%
39.8K vs 39.7K
Q2.24
-4%
38.3K vs 39.7K
Q3.24
-9%
38.3K vs 42.1K
Q4.24
-7%
38.6K vs 41.5K
Return on Equity
QoQ
Q1.23
+44%
0.44
vs 0.45
Q2.23
+37%
0.37
vs 0.44
Q3.23
+18%
0.18
vs 0.37
Q4.23
+73%
0.73
vs 0.18
Q1.24
+64%
0.64
vs 0.73
Q2.24
+96%
0.96
vs 0.64
Q3.24
+53%
0.53
vs 0.96
Q4.24
+30%
0.3
vs 0.53
Institutionnal Ownership
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
CNQ
0.01Â ( 1.45%)
Relative Strenght
Volume Buzz
-96%
Earning Acce
Yes
Dist 52w H.
0%Relative Strength
BUX.CN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How BUX.CN compares to sector?